SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-006749
Filing Date
2024-01-25
Accepted
2024-01-25 17:19:33
Documents
13
Period of Report
2024-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244105d1_8k.htm   iXBRL 8-K 26209
  Complete submission text file 0001104659-24-006749.txt   244883

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlsi-20240124.xsd EX-101.SCH 3281
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlsi-20240124_def.xml EX-101.DEF 26921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlsi-20240124_lab.xml EX-101.LAB 36508
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlsi-20240124_pre.xml EX-101.PRE 25545
7 EXTRACTED XBRL INSTANCE DOCUMENT tm244105d1_8k_htm.xml XML 4992
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39813 | Film No.: 24563234
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)